A Phase 2, Dose-Ranging, Randomized, Double-Blind,Placeb

Project: Research project

Project Details

Description

A Phase 2, Dose-Ranging, Randomized, Double-Blind,Placebo-Controlled Study of GS-4997 in Subjects with Pulmonary Arterial Hypertension
StatusFinished
Effective start/end date7/25/147/24/19

Funding

  • Gilead Sciences, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.